Therapy of genital herpes with topically applied interferon
- PMID: 3310870
- PMCID: PMC174885
- DOI: 10.1128/AAC.31.7.1137
Therapy of genital herpes with topically applied interferon
Abstract
Ninety-four patients with recurrences of genital herpes were randomized in a double-blind trial to receive topical therapy for 5 days with either alpha-2a interferon at 30 X 10(6) IU/ml or 10 X 10(6) IU/ml or placebo six times daily. No differences were noted between either interferon dose and placebo with respect to the duration of viral shedding, the time to crusting, or the time to healing of herpetic lesions. Aqueous solutions of alpha-2a interferon applied topically to unroofed vesicles do not appear to be clinically useful in the treatment of recurrences of genital herpes.
Similar articles
-
Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes.J Infect Dis. 1990 Apr;161(4):692-8. doi: 10.1093/infdis/161.4.692. J Infect Dis. 1990. PMID: 2156945 Clinical Trial.
-
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis.Antiviral Res. 1992 Mar;17(3):235-43. doi: 10.1016/0166-3542(92)90044-6. Antiviral Res. 1992. PMID: 1567188 Clinical Trial.
-
Placebo-controlled trial of topical interferon in labial and genital herpes.Lancet. 1988 Jan 23;1(8578):150-2. doi: 10.1016/s0140-6736(88)92723-7. Lancet. 1988. PMID: 2892991 Clinical Trial.
-
Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy.J Antimicrob Chemother. 1983 Sep;12 Suppl B:67-77. doi: 10.1093/jac/12.suppl_b.67. J Antimicrob Chemother. 1983. PMID: 6355053 Review.
-
Genital herpes - the disease and its treatment including intravenous acyclovir.J Antimicrob Chemother. 1983 Sep;12 Suppl B:51-9. doi: 10.1093/jac/12.suppl_b.51. J Antimicrob Chemother. 1983. PMID: 6355051 Review.
Cited by
-
Medical treatment of viral pneumonia including SARS in immunocompetent adult.J Infect. 2004 Nov;49(4):262-73. doi: 10.1016/j.jinf.2004.07.010. J Infect. 2004. PMID: 15474623 Free PMC article. Review.
-
Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections.Antimicrob Agents Chemother. 1989 Sep;33(9):1511-5. doi: 10.1128/AAC.33.9.1511. Antimicrob Agents Chemother. 1989. PMID: 2479335 Free PMC article.
-
Current recommendations for the treatment of genital herpes.Drugs. 2000 Dec;60(6):1329-52. doi: 10.2165/00003495-200060060-00007. Drugs. 2000. PMID: 11152015 Review.
-
Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies.Antimicrob Agents Chemother. 1990 Jan;34(1):107-10. doi: 10.1128/AAC.34.1.107. Antimicrob Agents Chemother. 1990. PMID: 1691613 Free PMC article.
-
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.J Clin Virol. 2004 Sep;31(1):69-75. doi: 10.1016/j.jcv.2004.03.003. J Clin Virol. 2004. PMID: 15288617 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical